Provider

As opioid abuse continues to make impact in the US, more and more tech-driven answers to the drug crisis are springing up that aim to reduce patients’ reliance on prescription opioids.

The Department of Veterans Affairs has announced a research partnership with Alphabet subsidiary DeepMind that will tackle issues concerning patient deterioration during hospital care.

Medication management app maker Medisafe has a guiding principle when it comes to the difficult task of improving medication adherence: One size does not fit all.

At the HIMSS global conference, technology companies tend to use the gathering as an excuse to show off the latest features and advancements of their platform.

About the author: Emily Mitchell (PMP) is a senior manager within the Accenture Federal Services Health and Public Service practice.

Integration of a practitioner-developed mobile health system within a primary care setting was well-received by substance use disorder (SUD) patients and generally improved outcomes, according to a study recently published in the Journal of Medical Internet Research.

Implantable glucose sensor company Senseonics has launched a remote monitoring app for its users in Europe, the Middle East, and Africa, where its CGM system is distributed by Roche.

About the author: Naomi Fried, PhD, is the CEO of Health Innovation Strategies, which provides digital health strategy and innovation-program design and optimization consulting to healthcare stakeholders including pharma, payers, and providers.

Palo Alto, California-based Cognoa’s machine learning app for pediatric behavioral health has received categorization from the FDA as a diagnostic medical device for autism, according to an announcement from the company.

New York and Palo Alto, California-based MemoryMD has received FDA clearance for NeuroEEG, a wireless amplifier that transmits EEG signals to computers and cloud-based databases via Bluetooth.